Oppenheimer & Co’s Vaxart VXRT Stock Holding History

Oppenheimer & Co’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,950	Closed	-$17.2K	–	1741
2025 Q2	$17.2K	Buy	+37,950	New	+$16.5K	﹤0.01%	1597

Other funds holding VXRT

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

CFO

Custos Family Office Austin, Texas $147M AUM 17.83% 1-Year Est. Return

LCM

LVM Capital Management Portage, Michigan $1.19B AUM 41.5% 1-Year Est. Return

HWA

Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Oppenheimer & Co's VXRT Position: Q3 2025 in Review

Oppenheimer & Co sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 37,950 shares — an estimated $17.2K sold.

Oppenheimer & Co first reported a position in VXRT in Q2 2025 and held it in 1 quarter. The position peaked at $17.2K in Q2 2025. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

Oppenheimer & Co reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
Oppenheimer & Co sold 37,950 Vaxart shares in Q3 2025, an estimated $17.2K.
Oppenheimer & Co first reported a position in Vaxart in Q2 2025 and held it in 1 quarter.
Oppenheimer & Co's Vaxart position peaked at $17.2K in Q2 2025.
17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.